Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.810 EUR
57.41 M EUR
348.81 M EUR
47.41 M
About JAPAN LIFELINE CO
Sector
Industry
Website
Headquarters
Tokyo
Founded
1981
ISIN
JP3754500001
FIGI
BBG01S7TKNH5
Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JAPAN LIFELINE CO. stocks are traded under the ticker L8B.
We've gathered analysts' opinions on JAPAN LIFELINE CO. future price: according to them, L8B price has a max estimate of 10.50 EUR and a min estimate of 9.76 EUR. Watch L8B chart and read a more detailed JAPAN LIFELINE CO. stock forecast: see what analysts think of JAPAN LIFELINE CO. and suggest that you do with its stocks.
Yes, you can track JAPAN LIFELINE CO. financials in yearly and quarterly reports right on TradingView.
JAPAN LIFELINE CO. is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
JAPAN LIFELINE CO. revenue for the last quarter amounts to 85.02 M EUR, despite the estimated figure of 88.24 M EUR. In the next quarter, revenue is expected to reach 91.46 M EUR.
L8B net income for the last quarter is 13.84 M EUR, while the quarter before that showed 16.19 M EUR of net income which accounts for −14.54% change. Track more JAPAN LIFELINE CO. financial stats to get the full picture.
JAPAN LIFELINE CO. dividend yield was 3.47% in 2024, and payout ratio reached 40.33%. The year before the numbers were 3.45% and 42.54% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JAPAN LIFELINE CO. EBITDA is 81.92 M EUR, and current EBITDA margin is 25.47%. See more stats in JAPAN LIFELINE CO. financial statements.
Like other stocks, L8B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JAPAN LIFELINE CO. stock right from TradingView charts — choose your broker and connect to your account.